Financings Of The Fortnight And The Never-Ending Venture Round
This article was originally published in The Pink Sheet Daily
Executive Summary
While not as high-profile as some other venture raises over the last year, Novimmune has pulled in CHF 200.5 million in Series B financing over 16 years. Plus, news on raises by Pronutria, Melinta, Argos and Arrowhead.